ASX Announcement NOTICE OF DATE OF ANNUAL GENERAL MEETING AND OTHER RELEVANT DATES Melbourne, Australia – 12 August 2026: Pursuant to ASX Listing Rule 3.13.1 Percheron Therapeutics Limited (ASX: PER) ( Percheron or the Company ) is pleased to advise the following details...
Notice of date of AGM and other relevant dates
Filed with ASX · · 1 page · English
Summary by 6ix AI
Percheron Therapeutics Limited has announced the date of its upcoming Annual General Meeting and other relevant dates. The AGM is scheduled for a Wednesday in October, with specific details regarding nominations and participation provided. Shareholders will receive a Notice of Meeting, which will also be available on the company's website after dispatch. The company encourages shareholder participation at this year's AGM.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Percheron Therapeutics Limited on 6ix
Earlier from Percheron Therapeutics
- Percheron Therapeutics Announces CEO Succession
- Quarterly Activities Report and Appendix 4C
- Results of Entitlement Offer
- Prospectus - Non-renounceable Entitlement Offer
- Non-renounceable Entitlement Offer
Later from Percheron Therapeutics
- Application for quotation of securities - PER
- Appendix 4E and Annual Report
- Appendix 4G and Corporate Governance Statement
- Vanderbilt Health to conduct clinical trial of HMBD-002
- Trading Halt
Follow Percheron Therapeutics into a list and get an email when it puts out news.
Follow Percheron Therapeutics